Article
Impact of RUNX2 gene silencing on the gemcitabine sensitivity of p53‑mutated pancreatic cancer MiaPaCa‑2 spheres.
Oncology reports - 1 Jun 2018
Sang Meijie, Nakamura Mizuyo, Ogata Takehiro, Sun Dan, Shimozato Osamu, Nikaido Toshio, Ozaki Toshinori
Abstract excerpt
Recently, it has been well‑recognized that the response toward anticancer drugs differs between two‑ and three‑dimensional (2D and 3D) in vitro cancer cell growth models. In the present study, we have demonstrated that, similar to the conventional 2D monolayer culture systems which often lack in vivo physiological insights, RUNX2 gene silencing increases the gemcitabine (GEM) sensitivity of the 3D spheres...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
